Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study

BACKGROUND: The long-term safety and efficacy of fremanezumab were evaluated in a 52-week extension study (NCT02638103). Patient satisfaction with fremanezumab, dosing preferences, and patient-reported outcomes were assessed in a subpopulation who completed the extension study and consented to a fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Buse, Dawn C., Gandhi, Sanjay K., Cohen, Joshua M., Ramirez-Campos, Verena, Cloud, Blaine, Yang, Ronghua, Cowan, Robert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487845/
https://www.ncbi.nlm.nih.gov/pubmed/32887548
http://dx.doi.org/10.1186/s10194-020-01177-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487845/
https://www.ncbi.nlm.nih.gov/pubmed/32887548
http://dx.doi.org/10.1186/s10194-020-01177-4

Ejemplares similares